These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26023252)

  • 1. Therapeutic prospects for spinocerebellar ataxia type 2 and 3.
    Bezprozvanny I; Klockgether T
    Drugs Future; 2009 Dec; 34(12):. PubMed ID: 26023252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficits.
    Koppenol R; Conceição A; Afonso IT; Afonso-Reis R; Costa RG; Tomé S; Teixeira D; da Silva JP; Côdesso JM; Brito DVC; Mendonça L; Marcelo A; Pereira de Almeida L; Matos CA; Nóbrega C
    Brain; 2023 Jun; 146(6):2346-2363. PubMed ID: 36511898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
    Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
    Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra.
    Schöls L; Reimold M; Seidel K; Globas C; Brockmann K; Hauser TK; Auburger G; Bürk K; den Dunnen W; Reischl G; Korf HW; Brunt ER; Rüb U
    Brain; 2015 Nov; 138(Pt 11):3316-26. PubMed ID: 26362908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological Studies Support Utility of Positive Modulators of SK Channels for the Treatment of Spinocerebellar Ataxia Type 2.
    Egorova PA; Bezprozvanny IB
    Cerebellum; 2022 Oct; 21(5):742-749. PubMed ID: 34978024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3.
    Schmidt J; Schmidt T; Golla M; Lehmann L; Weber JJ; Hübener-Schmid J; Riess O
    J Neurochem; 2016 Jul; 138(1):150-62. PubMed ID: 26990650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2.
    Liu J; Tang TS; Tu H; Nelson O; Herndon E; Huynh DP; Pulst SM; Bezprozvanny I
    J Neurosci; 2009 Jul; 29(29):9148-62. PubMed ID: 19625506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine levels of the polyglutamine ataxin-3 protein are elevated in patients with spinocerebellar ataxia type 3.
    Koike Y; Jansen-West KR; Hanna Al-Shaikh R; Carlomagno Y; Song Y; Dunmore JA; LeDoux MS; Friedman JH; Pena AB; Uitti RJ; Zaremba J; van Gerpen JA; Pfeiffer RF; Veerappan V; Aiba I; Hashimoto R; Giles SS; Shah JS; Tipton PW; Huang JF; Wierenga KJ; Aasly J; Fryer JD; Petrucelli L; Wszolek ZK; Prudencio M
    Parkinsonism Relat Disord; 2021 Aug; 89():151-154. PubMed ID: 34303201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
    Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
    Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
    Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the distribution of intranuclear and cytoplasmic aggregates in the brainstem of patients with spinocerebellar ataxia type 2 and 3.
    Seidel K; Siswanto S; Fredrich M; Bouzrou M; den Dunnen WFA; Özerden I; Korf HW; Melegh B; de Vries JJ; Brunt ER; Auburger G; Rüb U
    Brain Pathol; 2017 May; 27(3):345-355. PubMed ID: 27377427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of inositol 1,4,5-trisphosphate receptors in pathogenesis of Huntington's disease and spinocerebellar ataxias.
    Bezprozvanny I
    Neurochem Res; 2011 Jul; 36(7):1186-97. PubMed ID: 21210219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive review of spinocerebellar ataxia type 2 in Cuba.
    Velázquez-Pérez L; Rodríguez-Labrada R; García-Rodríguez JC; Almaguer-Mederos LE; Cruz-Mariño T; Laffita-Mesa JM
    Cerebellum; 2011 Jun; 10(2):184-98. PubMed ID: 21399888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and ataxic symptom in the SCA3 transgenic mouse.
    Chou AH; Chen YL; Chiu CC; Yuan SJ; Weng YH; Yeh TH; Lin YL; Fang JM; Wang HL
    Neuropharmacology; 2015 Dec; 99():308-17. PubMed ID: 26254860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma PolyQ-ATXN3 Levels Associate With Cerebellar Degeneration and Behavioral Abnormalities in a New AAV-Based SCA3 Mouse Model.
    Jansen-West K; Todd TW; Daughrity LM; Yue M; Tong J; Carlomagno Y; Del Rosso G; Kurti A; Jones CY; Dunmore JA; Castanedes-Casey M; Dickson DW; Wszolek ZK; Fryer JD; Petrucelli L; Prudencio M
    Front Cell Dev Biol; 2022; 10():863089. PubMed ID: 35386195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3.
    Chen X; Tang TS; Tu H; Nelson O; Pook M; Hammer R; Nukina N; Bezprozvanny I
    J Neurosci; 2008 Nov; 28(48):12713-24. PubMed ID: 19036964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia.
    Geschwind DH; Perlman S; Figueroa CP; Treiman LJ; Pulst SM
    Am J Hum Genet; 1997 Apr; 60(4):842-50. PubMed ID: 9106530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 activation mediates polyglutamine-expanded ataxin-3 upregulation of Bax expression in cerebellar and pontine nuclei neurons.
    Chou AH; Lin AC; Hong KY; Hu SH; Chen YL; Chen JY; Wang HL
    Neurochem Int; 2011 Feb; 58(2):145-52. PubMed ID: 21092747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathoanatomy of cerebellar degeneration in spinocerebellar ataxia type 2 (SCA2) and type 3 (SCA3).
    Scherzed W; Brunt ER; Heinsen H; de Vos RA; Seidel K; Bürk K; Schöls L; Auburger G; Del Turco D; Deller T; Korf HW; den Dunnen WF; Rüb U
    Cerebellum; 2012 Sep; 11(3):749-60. PubMed ID: 22198871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Josephin domain (JD) containing proteins are predicted to bind to the same interactors: Implications for spinocerebellar ataxia type 3 (SCA3) studies using
    Sousa E Silva R; Sousa AD; Vieira J; Vieira CP
    Front Mol Neurosci; 2023; 16():1140719. PubMed ID: 37008788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.